Full text is available at the source.
Abstract
CRISPR-Cas9 gene editing holds significant potential as a therapeutic tool for cancer and other diseases.
- Recent advances in CRISPR-Cas9 technology may enhance its application in cancer treatment.
- Current barriers to clinical translation include challenges with delivering the technology effectively within the body.
- Off-target effects, where unintended parts of the genome are altered, are a concern that could impact safety.
- Potential strategies to mitigate these issues are being explored to improve the feasibility of CRISPR-Cas9 in clinical settings.
Simplified